Cardlytics, Inc. (NASDAQ:CDLX) Given Average Rating of “Hold” by Analysts

Shares of Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) have earned an average rating of “Hold” from the seven ratings firms that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $6.42.

Several brokerages recently issued reports on CDLX. Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a report on Thursday, March 13th. Lake Street Capital decreased their price objective on Cardlytics from $5.00 to $3.00 and set a “hold” rating for the company in a research note on Thursday, March 13th. Finally, Evercore ISI lowered their target price on shares of Cardlytics from $4.00 to $3.00 and set an “in-line” rating for the company in a research note on Thursday, March 13th.

Check Out Our Latest Stock Analysis on CDLX

Insider Activity

In other Cardlytics news, CFO Alexis Desieno sold 24,778 shares of the company’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $84,245.20. Following the completion of the transaction, the chief financial officer now owns 140,948 shares in the company, valued at approximately $479,223.20. This represents a 14.95 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Amit Gupta sold 46,857 shares of the firm’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $159,313.80. Following the completion of the sale, the chief executive officer now owns 418,637 shares of the company’s stock, valued at approximately $1,423,365.80. The trade was a 10.07 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 90,172 shares of company stock valued at $313,759 in the last ninety days. 4.40% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Cardlytics

A number of hedge funds and other institutional investors have recently modified their holdings of CDLX. Mirabella Financial Services LLP purchased a new position in shares of Cardlytics during the 4th quarter worth approximately $4,285,000. D. E. Shaw & Co. Inc. lifted its holdings in shares of Cardlytics by 97.4% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 1,131,505 shares of the company’s stock worth $4,198,000 after acquiring an additional 558,235 shares during the period. Rangeley Capital LLC purchased a new position in Cardlytics during the fourth quarter worth approximately $1,187,000. RBF Capital LLC boosted its holdings in Cardlytics by 64.7% in the fourth quarter. RBF Capital LLC now owns 803,763 shares of the company’s stock valued at $2,982,000 after acquiring an additional 315,635 shares during the last quarter. Finally, Millennium Management LLC acquired a new position in shares of Cardlytics in the 4th quarter valued at about $535,000. 68.10% of the stock is currently owned by institutional investors and hedge funds.

Cardlytics Price Performance

NASDAQ:CDLX opened at $1.41 on Tuesday. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.18 and a current ratio of 1.18. The stock has a market cap of $73.44 million, a PE ratio of -0.23 and a beta of 1.39. The stock has a 50 day moving average price of $2.33 and a 200 day moving average price of $3.21. Cardlytics has a one year low of $1.22 and a one year high of $15.89.

Cardlytics Company Profile

(Get Free Report

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Recommended Stories

Analyst Recommendations for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.